Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
TRDA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $218.43M
- EPS (TTM)
- -$4.09
- Dividend yield
- None
- 52-week range
- 5.15 – 16.45
- Day range
- 5.32 – 5.66
- Volume / Avg
- 297.44K / 362.82K
- Beta
- —
- Shares outstanding
- 38.94M
- Next earnings
- Nov 5, 2026
52-week range
TRDA stock today
On Oct 7, TRDA ended the session at $5.61, adding $0.19 (3.51%), versus the S&P 500's 0.22% decline. Shares are 65.9% below their 52-week high of $16.45, set on May 6, 2026 and 8.9% above the 52-week low of $5.15, near the bottom of the past year's range. TRDA is down 45.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 4.1%.
Entrada Therapeutics has posted a net loss over the last twelve months (EPS of -$4.09), so its P/E ratio is not meaningful. Entrada Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Entrada Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.98
Entrada Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SIONSionna Therapeutics Inc. | 4.82 | +1.47% | $217.62M | vs TRDA |
| NATRNature's Sunshine Products Inc. | 12.59 | +0.40% | $221.53M | vs TRDA |
| KROSKeros Therapeutics Inc. | 11.21 | +1.82% | $222.26M | vs TRDA |
| EVMNEvommune Inc. | 6.22 | -5.90% | $225.74M | vs TRDA |
| GLSIGreenwich LifeSciences Inc. | 15.39 | -2.53% | $225.90M | vs TRDA |
| MGNXMacroGenics Inc. | 3.55 | -2.47% | $226.14M | vs TRDA |
| LYELLyell Immunopharma Inc. | 8.56 | -0.58% | $209.76M | vs TRDA |
| IFRXInflaRx N.V. | 1.56 | -1.27% | $229.89M | vs TRDA |
Indexes, lists and sector
Entrada Therapeutics stock FAQ
What is Entrada Therapeutics's stock price today?
TRDA last traded at $5.61 as of Oct 7, 4:00 PM EDT, up 3.51% on the day. Prices are delayed at least 15 minutes.
When is Entrada Therapeutics's next earnings date?
Entrada Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.98.
What is the TRDA 52-week high?
The 52-week high for TRDA is $16.45 and the 52-week low is $5.15. The stock is currently 65.9% below its high.